Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Takemoto

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Geriatrics & Gerontology International|November 23, 2020
Management guideline for Werner syndrome 2020. 6. Skin ulcers associated with Werner syndrome: Prevention and non-surgical and surgical treatmentYoshitaka Kubota, Minoru Takemoto, Toshibumi Taniguchi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2019
A Case of Hashimoto's Thyroiditis with Multiple Drug Resistance and High Expression of Efflux TransportersTomohiko Yoshida, Akitoshi Nakayama, Ai Tamura, et al.
Geriatrics & Gerontology International|December 1, 2020
Management guideline for Werner syndrome 2020 1. Dyslipidemia and fatty liver associated with Werner syndromeKazuhisa Tsukamoto, Minoru Takemoto, Yoshitaka Kubota, et al.
Frontiers in Endocrinology|May 15, 2026
Anti-GIP antibodies and future diabetes related risk: an eight-year prospective cohort studyTakahide Hashimoto, Naoki Ohtake, Tokiko Okamoto, et al.
Internal Medicine (Tokyo, Japan)|December 21, 2018
Characteristic Clinical Features of Werner Syndrome with a Novel Compound Heterozygous WRN Mutation c.1720+1G>A Plus c.3139-1G>CNamiko Matsumoto, Yasuyuki Ohta, Kentaro Deguchi, et al.
Journal of the American Society of Nephrology : JASN|January 26, 2007
Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066E14RikJaakko Patrakka, Zhijie Xiao, Masatoshi Nukui, et al.
Journal of Diabetes Investigation|March 25, 2015
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trialHidetaka Yokoh, Kazuki Kobayashi, Yasunori Sato, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|May 26, 2022
Rothmund-Thomson syndrome investigated by two nationwide surveys in JapanHideo Kaneko, Minoru Takemoto, Hiroaki Murakami, et al.
Geriatrics & Gerontology International|December 1, 2020
Management guideline for Werner syndrome 2020 8. Calcification in tendons associated with Werner syndromeAkira Taniguchi, Yasuhito Tanaka, Minoru Takemoto, et al.
Scientific Reports|November 3, 2025
Increased autoantibodies against incretin indicate poor prognosis in patients with diabetesMinoru Takemoto, Bo-Shi Zhang, Aiko Hayashi, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Geriatrics & Gerontology International|November 23, 2020
Management guideline for Werner syndrome 2020. 6. Skin ulcers associated with Werner syndrome: Prevention and non-surgical and surgical treatmentYoshitaka Kubota, Minoru Takemoto, Toshibumi Taniguchi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2019
A Case of Hashimoto's Thyroiditis with Multiple Drug Resistance and High Expression of Efflux TransportersTomohiko Yoshida, Akitoshi Nakayama, Ai Tamura, et al.
Geriatrics & Gerontology International|December 1, 2020
Management guideline for Werner syndrome 2020 1. Dyslipidemia and fatty liver associated with Werner syndromeKazuhisa Tsukamoto, Minoru Takemoto, Yoshitaka Kubota, et al.
Frontiers in Endocrinology|May 15, 2026
Anti-GIP antibodies and future diabetes related risk: an eight-year prospective cohort studyTakahide Hashimoto, Naoki Ohtake, Tokiko Okamoto, et al.
Internal Medicine (Tokyo, Japan)|December 21, 2018
Characteristic Clinical Features of Werner Syndrome with a Novel Compound Heterozygous WRN Mutation c.1720+1G>A Plus c.3139-1G>CNamiko Matsumoto, Yasuyuki Ohta, Kentaro Deguchi, et al.
Journal of the American Society of Nephrology : JASN|January 26, 2007
Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066E14RikJaakko Patrakka, Zhijie Xiao, Masatoshi Nukui, et al.
Journal of Diabetes Investigation|March 25, 2015
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trialHidetaka Yokoh, Kazuki Kobayashi, Yasunori Sato, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|May 26, 2022
Rothmund-Thomson syndrome investigated by two nationwide surveys in JapanHideo Kaneko, Minoru Takemoto, Hiroaki Murakami, et al.
Geriatrics & Gerontology International|December 1, 2020
Management guideline for Werner syndrome 2020 8. Calcification in tendons associated with Werner syndromeAkira Taniguchi, Yasuhito Tanaka, Minoru Takemoto, et al.
Scientific Reports|November 3, 2025
Increased autoantibodies against incretin indicate poor prognosis in patients with diabetesMinoru Takemoto, Bo-Shi Zhang, Aiko Hayashi, et al.
Pageof 15